Logo image of BKYI

BIO-KEY INTERNATIONAL INC (BKYI) Stock Fundamental Analysis

USA - NASDAQ:BKYI - US09060C5076 - Common Stock

0.746 USD
-0.03 (-4.36%)
Last: 11/3/2025, 2:36:29 PM
Fundamental Rating

2

BKYI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. BKYI may be in some trouble as it scores bad on both profitability and health. BKYI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year BKYI has reported negative net income.
BKYI had a negative operating cash flow in the past year.
BKYI had negative earnings in each of the past 5 years.
BKYI had a negative operating cash flow in each of the past 5 years.
BKYI Yearly Net Income VS EBIT VS OCF VS FCFBKYI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

BKYI has a worse Return On Assets (-38.30%) than 79.58% of its industry peers.
The Return On Equity of BKYI (-58.78%) is worse than 71.48% of its industry peers.
Industry RankSector Rank
ROA -38.3%
ROE -58.78%
ROIC N/A
ROA(3y)-114.53%
ROA(5y)-83.12%
ROE(3y)-379.98%
ROE(5y)-244.11%
ROIC(3y)N/A
ROIC(5y)N/A
BKYI Yearly ROA, ROE, ROICBKYI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

The Gross Margin of BKYI (78.71%) is better than 77.11% of its industry peers.
BKYI's Gross Margin has improved in the last couple of years.
BKYI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.53%
GM growth 5YN/A
BKYI Yearly Profit, Operating, Gross MarginsBKYI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

2

2. Health

2.1 Basic Checks

BKYI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BKYI has more shares outstanding
Compared to 5 years ago, BKYI has more shares outstanding
BKYI has a worse debt/assets ratio than last year.
BKYI Yearly Shares OutstandingBKYI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BKYI Yearly Total Debt VS Total AssetsBKYI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -17.00, we must say that BKYI is in the distress zone and has some risk of bankruptcy.
BKYI has a Altman-Z score of -17.00. This is amonst the worse of the industry: BKYI underperforms 91.90% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that BKYI is not too dependend on debt financing.
BKYI has a Debt to Equity ratio (0.07) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -17
ROIC/WACCN/A
WACC12.34%
BKYI Yearly LT Debt VS Equity VS FCFBKYI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 1.14 indicates that BKYI should not have too much problems paying its short term obligations.
With a Current ratio value of 1.14, BKYI is not doing good in the industry: 65.85% of the companies in the same industry are doing better.
A Quick Ratio of 1.05 indicates that BKYI should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.05, BKYI is doing worse than 68.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.05
BKYI Yearly Current Assets VS Current LiabilitesBKYI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

5

3. Growth

3.1 Past

BKYI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.08%, which is quite impressive.
Looking at the last year, BKYI shows a quite strong growth in Revenue. The Revenue has grown by 13.96% in the last year.
The Revenue has been growing by 25.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)89.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y10.69%
Revenue growth 5Y25.01%
Sales Q2Q%48.69%

3.2 Future

BKYI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.20% yearly.
Based on estimates for the next years, BKYI will show a small growth in Revenue. The Revenue will grow by 7.75% on average per year.
EPS Next Y73.12%
EPS Next 2Y35.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.83%
Revenue Next 2Y7.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BKYI Yearly Revenue VS EstimatesBKYI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
BKYI Yearly EPS VS EstimatesBKYI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -20 -40 -60 -80 -100

1

4. Valuation

4.1 Price/Earnings Ratio

BKYI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BKYI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKYI Price Earnings VS Forward Price EarningsBKYI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BKYI Per share dataBKYI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as BKYI's earnings are expected to grow with 35.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.2%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BKYI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BIO-KEY INTERNATIONAL INC

NASDAQ:BKYI (11/3/2025, 2:36:29 PM)

0.746

-0.03 (-4.36%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-12 2025-11-12
Inst Owners1.75%
Inst Owner Change0%
Ins Owners5.98%
Ins Owner Change6.34%
Market Cap5.12M
Revenue(TTM)6.91M
Net Income(TTM)-4027500
Analysts82.86
Price Target2.04 (173.46%)
Short Float %0.36%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)25%
EPS NY rev (1m)0%
EPS NY rev (3m)9.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.74
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.87
EV/EBITDA N/A
EPS(TTM)-1.2
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS1.01
BVpS1
TBVpS0.86
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.3%
ROE -58.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.71%
FCFM N/A
ROA(3y)-114.53%
ROA(5y)-83.12%
ROE(3y)-379.98%
ROE(5y)-244.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.53%
GM growth 5YN/A
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.92%
Cap/Sales 0.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.05
Altman-Z -17
F-Score5
WACC12.34%
ROIC/WACCN/A
Cap/Depr(3y)8.01%
Cap/Depr(5y)11.47%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y73.12%
EPS Next 2Y35.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y10.69%
Revenue growth 5Y25.01%
Sales Q2Q%48.69%
Revenue Next Year-5.83%
Revenue Next 2Y7.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y62.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.9%
OCF growth 3YN/A
OCF growth 5YN/A

BIO-KEY INTERNATIONAL INC / BKYI FAQ

What is the fundamental rating for BKYI stock?

ChartMill assigns a fundamental rating of 2 / 10 to BKYI.


Can you provide the valuation status for BIO-KEY INTERNATIONAL INC?

ChartMill assigns a valuation rating of 1 / 10 to BIO-KEY INTERNATIONAL INC (BKYI). This can be considered as Overvalued.


How profitable is BIO-KEY INTERNATIONAL INC (BKYI) stock?

BIO-KEY INTERNATIONAL INC (BKYI) has a profitability rating of 1 / 10.


Can you provide the financial health for BKYI stock?

The financial health rating of BIO-KEY INTERNATIONAL INC (BKYI) is 2 / 10.